Acute and chronic nephrotoxicity of platinum nanoparticles in mice

Nanoscale Research Letters

Volumn 8, Issue 1, 2013, Pages 1-7

  Yamagishi, Yoshiaki ^a   Watari, Akihiro ^a   Hayata, Yuya ^a   Li, Xiangru ^a   Kondoh, Masuo ^a   Yoshioka, Yasuo ^a   Tsutsumi, Yasuo ^a   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Kidney; Nanosized materials; Nephrotoxicity; Platinum particles; Safety evaluation

Indexed keywords

CELL DEATH; DIETARY SUPPLEMENTS; INDUSTRIAL POISONS; MAMMALS; NANOPARTICLES; PHYSICOCHEMICAL PROPERTIES; PLATINUM; UREA;

KIDNEY; NANOSIZED MATERIALS; NEPHROTOXICITY; PLATINUM PARTICLES; SAFETY EVALUATIONS;

PARTICLE SIZE ANALYSIS;

MUS;

EID: 84887301059     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-8-395     Document Type: Article

References (41)

1. Ariga K, Hu X, Mandal S, Hill JP: By what means should nanoscaled materials be constructed: molecule, medium, or human? Nanoscale 2010, 2:198-214.
2. Service RF: U.S. nanotechnology. Health and safety research slated for sizable gains. Science 2007, 315:926.
3. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P: Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 2010, 62:346-361.
4. Aiso S, Yamazaki K, Umeda Y, Asakura M, Kasai T, Takaya M, Toya T, Koda S, Nagano K, Arito H, Fukushima S: Pulmonary toxicity of intratracheally instilled multiwall carbon nanotubes in male Fischer 344 rats. Ind Health 2010, 48:783-795.
5. Murray AR, Kisin E, Leonard SS, Young SH, Kommineni C, Kagan VE, Castranova V, Shvedova AA: Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes. Toxicology 2009, 257:161-171.
6. Yamashita K, Yoshioka Y, Higashisaka K, Morishita Y, Yoshida T, Fujimura M, Kayamuro H, Nabeshi H, Yamashita T, Nagano K, Abe Y, Kamada H, Kawai Y, Mayumi T, Yoshikawa T, Itoh N, Tsunoda S, Tsutsumi Y: Carbon nanotubes elicit DNA damage and inflammatory response relative to their size and shape. Inflammation 2010, 33:276-280.
7. Warheit DB, Reed KL, Sayes CM: A role for nanoparticle surface reactivity in facilitating pulmonary toxicity and development of a base set of hazard assays as a component of nanoparticle risk management. Inhal Toxicol 2009, 21(Suppl 1):61-67.
8. Chen J, Dong X, Zhao J, Tang G: In vivo acute toxicity of titanium dioxide nanoparticles to mice after intraperitioneal injection. J Appl Toxicol: JAT 2009, 29:330-337.
9. Geys J, Nemmar A, Verbeken E, Smolders E, Ratoi M, Hoylaerts MF, Nemery B, Hoet PH: Acute toxicity and prothrombotic effects of quantum dots: impact of surface charge. Environ Health Perspect 2008, 116:1607-1613.
10. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K: Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 2009, 72:496-501.
11. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K: Histological analysis of 70-nm silica particles-induced chronic toxicity in mice. Eur J Pharm Biopharm: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV 2009, 72:626-629.
12. Park EJ, Kim H, Kim Y, Yi J, Choi K, Park K: Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. Toxicol Appl Pharmacol 2010, 244:226-233.
13. Nabeshi H, Yoshikawa T, Arimori A, Yoshida T, Tochigi S, Hirai T, Akase T, Nagano K, Abe Y, Kamada H, Tsunoda S, Itoh N, Yoshioka Y, Tsutsumi Y: Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Research Letters 2011, 6:93.
14. Hauck TS, Ghazani AA, Chan WC: Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 2008, 4:153-159.
15. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Frohlich E: The role of nanoparticle size in hemocompatibility. Toxicology 2009, 258:139-147.
16. Nafee N, Schneider M, Schaefer UF, Lehr CM: Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile. Int J Pharm 2009, 381:130-139.
17. Horie M, Kato H, Endoh S, Fujita K, Nishio K, Komaba LK, Fukui H, Nakamura A, Miyauchi A, Nakazato T, Kinugasa S, Yoshida Y, Hagihara Y, Morimoto Y, Iwahashi H: Evaluation of cellular influences of platinum nanoparticles by stable medium dispersion. Metallomics: Integrated Biometal Science 2011, 3:1244-1252.
18. Gehrke H, Pelka J, Hartinger CG, Blank H, Bleimund F, Schneider R, Gerthsen D, Brase S, Crone M, Turk M, Marko D: Platinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrations. Arch Toxicol 2011, 85:799-812.
19. Park EJ, Kim H, Kim Y, Park K: Intratracheal instillation of platinum nanoparticles may induce inflammatory responses in mice. Arch Pharm Res 2010, 33:727-735.
20. Pelka J, Gehrke H, Esselen M, Turk M, Crone M, Brase S, Muller T, Blank H, Send W, Zibat V, Brenner P, Schneider R, Gerthsen D, Marko D: Cellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrity. Chem Res Toxicol 2009, 22:649-659.
21. Onizawa S, Aoshiba K, Kajita M, Miyamoto Y, Nagai A: Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke. Pulm Pharmacol Therapeut 2009, 22:340-349.
22. Watanabe A, Kajita M, Kim J, Kanayama A, Takahashi K, Mashino T, Miyamoto Y: In vitro free radical scavenging activity of platinum nanoparticles. Nanotechnology 2009, 20:455105.
23. Kajita M, Hikosaka K, Iitsuka M, Kanayama A, Toshima N, Miyamoto Y: Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res 2007, 41:615-626.
24. Yamagishi Y, Watari A, Hayata Y, Li X, Kondoh M, Tsutsumi Y, Yagi K: Hepatotoxicity of sub-nanosized platinum particles in mice. Pharmazie 2013, 68:178-182.
25. Oberdorster G: Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 2010, 267:89-105.
26. Jiang J, Oberdorster G, Elder A, Gelein R, Mercer P, Biswas P: Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2008, 2:33-42.
27. Zhu MT, Feng WY, Wang B, Wang TC, Gu YQ, Wang M, Wang Y, Ouyang H, Zhao YL, Chai ZF: Comparative study of pulmonary responses to nanoand submicron-sized ferric oxide in rats. Toxicology 2008, 247:102-111.
28. Furuyama A, Kanno S, Kobayashi T, Hirano S: Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch Toxicol 2009, 83:429-437.
29. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C: Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445.
30. Ai J, Biazar E, Jafarpour M, Montazeri M, Majdi A, Aminifard S, Zafari M, Akbari HR, Rad HG: Nanotoxicology and nanoparticle safety in biomedical designs. Int J Nanomedicine 2011, 6:1117-1127.
31. Ruggiero A, Villa CH, Holland JP, Sprinkle SR, May C, Lewis JS, Scheinberg DA, McDevitt MR: Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes. Int J Nanomedicine 2010, 5:783-802.
32. Longmire M, Choyke PL, Kobayashi H: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 2008, 3:703-717.
33. Daugaard G: Cisplatin nephrotoxicity: experimental and clinical studies. Dan Med Bull 1990, 37:1-12.
34. Brabec V, Kasparkova J: Modifications of DNA by platinum complexes. Relation to resistance of tumors to platinum antitumor drugs. Drug Resist Updat 2005, 8:131-146.
35. Wang D, Lippard SJ: Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005, 4:307-320.
36. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW: Mechanism of cisplatinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Therapeut 1980, 213:551-556.
37. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB: Mechanisms of cisplatin nephrotoxicity. Toxins 2010, 2:2490-2518.
38. Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM: Distribution and disposition of platinum following intravenous administration of cisdiamminedichloroplatinum(II) (NSC 119875) to dogs. Cancer Res 1976, 36:2340-2344.
39. Asharani PV, Xinyi N, Hande MP, Valiyaveettil S: DNA damage and p53- mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine (Lond) 2010, 5:51-64.
40. Tanihara Y, Masuda S, Katsura T, Inui K: Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2. Biochem Pharmacol 2009, 78:1263-1271.
41. Yonezawa A, Inui K: Organic cation transporter OCT/SLC22A and H (+)/organic cation antiporter MATE/SLC47A are key molecules for nephrotoxicity of platinum agents. Biochem Pharmacol 2011, 81:563-568.